Aim The study aimed to investigate whether textural features of rectal cancer on MRI can predict long-term survival in patients treated with long-course chemoradiotherapy.
Introduction
Currently the standard management of locally advanced rectal cancer is neoadjuvant chemoradiotherapy (CRT) followed by total mesorectal excision [1] . This strategy combined with high resolution MRI has shown considerable improvement in locoregional control. This is not the case, however, for systemic control and these strategies may not necessarily improve survival [2] . Furthermore, restaging of irradiated rectal cancer is difficult owing to the difficulty MRI has in differentiating fibrosis from viable tumour [3] . In addition, a proportion of such patients will have achieved complete clinical response and could benefit from either a 'wait and watch' approach or less invasive local excision [4] . There is a poor correlation, however, of a clinical complete response with a true pathological complete response (pCR) [5] . This has resulted in the recent interest in the quantification of imaging biomarkers linked to underlying intra-tumour heterogeneity [6] associated with the adverse outcomes of treatment failure and drug resistance [7, 8] . Heterogeneity can be quantified non-invasively by imaging using textural analysis (TA). TA assesses the distribution of pixel grey-level intensity and the coarseness and regularity of digital images [9] . In the last decade, TA has been employed in oncological studies of lung [10] , brain [11] , renal [12] and breast [13] cancer as a diagnostic, prognostic and treatment response imaging biomarker. To date there has been no study to assess the potential of MRIbased TA (MRTA) in predicting survival in rectal cancer but a few studies have explored the potential of CTbased TA as a prognostic tool to assess survival in patients with colorectal cancer [14, 15] . The main object of the present study was to investigate whether MRTA in rectal cancer can predict long-term survival.
Method Patient selection
Ethical approval was obtained from the institutional ethics committee. A retrospective cohort was included of consecutive patients with Stage II and III MRIdefined poor risk, histologically confirmed primary nonmetastatic rectal adenocarcinoma originating within 15 cm of the anal verge and treated with long-course CRT with curative intent from January 2006 to June 2011. MRI-defined features of poor risk were a T3 tumour with > 5 mm infiltration into the perirectal fat, T4 tumours, N1 or N2 tumours and tumours with a threatened or involved circumferential resection margin (CRM) [16] . Details of long-course CRT protocol, technical and operative specifications are described elsewhere [17] .
MR protocols and acquisition parameters
MRI was performed with the same GE Sigma Genesis 1.5-T (software version 9.0) whole-body system using a torso coil (phased array) and a standard imaging protocol without intravenous contrast enhancement (Appendix S1). Restaging CT of the chest, abdomen and a pelvic MRI scan were performed approximately 6 weeks after the completion of CRT. Following multidisciplinary team review, a date for surgery was arranged for patients with no response or with evidence of substantial downstaging. Those with a partial response were further followed and a second MRI was performed 4 weeks after the first staging MRI, to optimize the timing of surgery at the point of maximal response [18] .
Image interpretation
T staging of tumour at pre-treatment (mrT) and posttreatment (ymrT) was standardized (Appendix S2) and based on the interpretation of local extent of persistent tumour signal intensity relative to the layers of bowel wall on T2-weighted images [19, 20] . Nodal stage at baseline (mrN) and after CRT (ymrN) was based on the interpretation of lymph node border characteristics and signal intensity. A node was regarded as positive if either an irregular border or mixed signal intensity was demonstrated [21] . Pre-and post-treatment CRM involvement (mrCRM and ymrCRM) was predicted to be clear if the distance of the tumour from the mesorectal fascia was greater than or equal to 1 mm. Pre-and post-treatment extramural venous invasion (mrEMVI and ymrEMVI) was visualized as an intermediate signal intensity apparent within vessels with accompanying nodular expansion of the vessel or an irregular vessel contour [22] . The tumour response to CRT was defined by MRI both on the pathological tumour regression grade (TRG) originally described by Dworak (Appendix S3) [14, 23] and on a modified Response Evaluation Criteria in Solid Tumours (RECIST) based on the maximum tumour length measured in the sagittal plane [24, 25] . For RECIST, a partial response to treatment was defined as at least a 30% decrease in tumour length in relation to the baseline tumour length. Progression of disease was defined as at least a 20% increase in tumour length and stable disease was defined as neither sufficient shrinkage to qualify for a partial response nor a sufficient increase to qualify for progression of disease. MRI scans were reviewed by two independent radiologists (AA, UP) blinded to the clinical outcome. Any discrepancy in reporting was resolved by discussion and consensus when required.
MR textural analysis (MRTA)
T2-weighted pre-treatment and a 6-week post-CRT MRI were used for MRTA. Regions of interest (ROIs) enclosing the largest cross-sectional area of tumour area were manually delineated on the axial images under the supervision of a gastrointestinal radiologist (AA) with 7 years' experience. The ROIs underwent TA under the supervision of an imaging scientist (BG) with 9 years' experience in TA using proprietary commercially available TEXRAD RESEARCH software (version 3.3, TexRAD Ltd, www.texrad.com, part of Feedback Plc, Cambridge, UK) [26] . MRTA comprised an image filtration-histogram approach where the filtration step employed a Laplacian of Gaussian band-pass spatial scale filter (SSF) to highlight features ranging from SSF = 2 mm (fine) to SSF = 6 mm (coarse) in radius with SSF = 3-5 mm in radius corresponding to medium texture scales (Fig. 1) . This scale can be considered as the width at which structures in the image will be highlighted and enhanced, while structures less than this width will become blurred [8] . Histogram analysis comprised quantifying first-order statistics of mean grey-level intensity, standard deviation, entropy, mean of positive pixels (MPP), kurtosis and skewness of the rectal ROI. A recent paper [27] describes the above parameters in detail and what these parameters mean in terms of image features. These parameters have further been shown to be associated with underlying histological features reflecting tumour heterogeneity (solid cancerous tissue, necrosis, angiogenesis, hypoxia and fibrosis [28, 29] ), predicting the response to neoadjuvant CRT [30] and survival [8, 22] as a potential imaging biomarker.
Histopathological examination of the resected specimen
The histopathological information was retrieved from the institutional pathology database. All the reports contained a standard dataset of histopathology results such as post-treatment pathological T and N stage (ypT and ypN) and included the information regarding the CRM (ypCRM) involvement according to rectal carcinoma guidelines of the Royal College of Pathologists [31] .
Survival
Overall survival (OS), disease-free survival (DFS) and relapse-free survival (RFS) were measured. All observations were censored at the date of the last follow-up or at the time lost to follow-up. The duration of follow-up was calculated from the date of diagnosis to death, last contact or date of conclusion of the study (21 March 2014) , whichever came first. OS was defined as the time from the date of diagnosis to death from any cause. DFS was defined as the time from the date of diagnosis to any event, irrespective of the cause. RFS was defined as the time from the date of diagnosis to any event except for second primary same or other cancers that were ignored [32] . Local recurrence was defined as evidence of recurrent tumour mass within the pelvis or in the perineum after a surgical resection [33] .
Data analysis
Clinical, MR and histopathological variables were categorized in a binary fashion to enable comparison by multivariate analysis. Clinical variables included age, gender, adjuvant chemotherapy and major postoperative complications based on the Clavien-Dindo classification for surgical complications [34] . Tumours were categorized into favourable and unfavourable responders to enable binary comparison by multivariate analysis. Based on the known histopathological outcome, favourable mrT and ymrT stages were defined as Stages T0, T1, T2 and T3a and unfavourable mrT and ymrT stages were defined as Stages T3b, T3c, T3d or T4. Stage T3a and T2 tumours have a similar outcome and therefore were both classified as favourable. Favourable mrN, ymrN and ypN were defined as N0, while node positivity was unfavourable. Favourable mrEMVI, ymrEMVI was defined as having no EMVI, while the presence of EMVI was unfavourable. A favourable MRI tumour regression grade (mrTRG) was defined as Grades 1, 2 and 3 that included tumours with a fibrotic stroma of 50% or more while unfavourable was defined as Grades 4 and 5 that included tumours in which cancer predominated with minimal or no fibrosis. Similarly a favourable histopathological TRG was defined by Dworak Stages 2, 3 and 4 while an unfavourable TRG was defined as Grades 0 and 1. For analysis of the length of the tumour, a partial response was categorized as favourable, while stable or progression of disease was unfavourable.
Statistical analysis
Continuous variables were expressed as means and SDs and categorical variables were expressed as percentages and 95% CIs. Univariate Kaplan-Meier survival analysis was employed to identify which texture parameter predicted survival, which further required the identification of the best 'optimal' cut-off at which the good and poor survival patient groups were optimally separated (lowest P value from the log-rank test which assessed the difference between the Kaplan-Meier curves) for each parameter. A P value < 0.05 was considered to be significant. Due to small numbers, significant textural parameters yielding less than 10 patients per group for comparison were not reported and hence were censored. Multivariate Cox regression analysis (forward Wald) was used to determine which of the significant univariate variables were independent predictors of outcome. Analysis was performed separately for pre-and post-treatment variables. The hazard ratio (HR) was determined for the variables where HR > 1 indicated increased risk of an event associated with the variable and HR < 1 indicated a reduced risk related to survival. Statistical analysis was performed using R software (version 2.14.2; R Foundation for Statistical Computing, Vienna, Austria) and SPSS (version 20; IBM Corp., Armonk, New York, USA).
Results
The study population consisted of 56 patients (34 male, 22 female) with mean age 64 AE 8.8 years. Complete pathological response (T0N0) was observed in 21% of patients (n = 12). Overall recurrence was observed in [23] . †Clavien classification of surgical complications [34] .
23% of patients (n = 13). The rate of distant and local recurrence was 20% and 5% (Table 1) . Pre-and posttreatment MR TNM staging is shown in 
Survival
Overall survival
Pre-treatment variables MRTA was a significant marker of OS on univariate analysis with MPP (fine texture scale) being the best (P = 0.008, Table 3 ). Positive mrEMVI status (P = 0.017, Table 4 ) and threatened mrCRM (P = 0.036, Table 4 ) were also significant MR factors. The clinical variable of a major complication also predicted a worse OS (P = 0.002) but as this was a postoperative rather than a pre-treatment or post-treatment factor it was not included in the multivariate analysis. On multivariate analysis, MPP on fine texture scale (HR 6.9, 95% CI: 2.4-19.5, P < 0.001), MPP on medium texture scale (HR 5.7, 95% CI: 1.6-20.2, P = 0.007) and mrEMVI positive status (HR 2.9, 95% CI: 1-8.3, P = 0.041) were the only independent predictors of OS (Table 5 , Fig 2a, b,c).
Post-treatment variables
Texture feature skewness at fine texture scale was the only univariate marker of OS on post-treatment MRTA (P = 0.034, Table 3 ). Positive ymrEMVI status (P = 0.002, Table 4 ), threatened ymrCRM (P = 0.027, Table 4 ) and poorer ymrTRG (P = 0.002, Table 4 ) predicted a worse OS. Among the Fig. 2d ) was the only independent predictor of OS (HR 4.2, 95% CI: 1.4-12.6, P = 0.01).
Disease-free survival
Pre-treatment variables A threatened mrCRM (P = 0.006, Table 4 ) and MRTA (best feature mean at medium texture, Table 3 ) were significant markers for DFS on univariate analysis. On multivariate analysis, MPP at fine texture scale (HR 3.3, 95% CI: 1.3-8.3, P = 0.008), mean MPP at medium texture scale (HR 4.5, 95% CI: 1.5-12.9, P = 0.003) and threatened mrCRM (HR 3.1, 95% CI: 1-9.4, P = 0.046) were the only independent predictors of DFS (Table 5 , Fig 3a,b,c) .
Post-treatment variables
Post-treatment MRTA (best was kurtosis at medium texture scale, P = 0.009, Table 3 ), positive mrEMVI CRM, circumferential resection margin; EMVI, extramural venous invasion; pCR, pathological complete response; RECIST, Response Evaluation Criteria in Solid Tumours; TRG, tumour regression grade. status (P = 0.017, Table 4 ), threatened mrCRM (P = 0.019, Table 4 ), mrTRG (P = 0.02, Table 4 ) and ypCRM (P = 0.035, Table 4 ) were significant markers of DFS on univariate analysis. On multivariate analysis, kurtosis at medium texture scale (HR 3.9, 95% CI: 1.4-10.9, P = 0.007) and ymrCRM involvement (HR 3.3, 95% CI: 1.2-9.3, P = 0.02) were the only independent predictors of DFS (Table 5 , Fig 3d,e) .
Relapse-free survival
Pre-treatment variables A threatened mrCRM (P = 0.016, Table 4 ) and MRTA were significant markers for RFS on univariate analysis (Table 3 ).The best textural features were standard deviation and entropy at coarse texture (P = 0.011) and MPP at fine and medium textures (P = 0.011). Using multivariate analysis, texture parameters of MPP at fine texture scale (HR 8.9, 95% CI: 2.3-33.1, P = 0.001) and kurtosis at medium texture scale (HR 7.7, 95% CI: 2-29, P = 0.002) were the only independent predictors (Table 5 , Fig 4a,b) .
Post-treatment variables
Post-treatment MRTA (best was entropy at coarse texture, P = 0.002, Table 3 ), ymrN stage (P = 0.024, Table 4 ), ypCRM involvement (P = 0.009, Table 4 ) and pathological complete response (P = 0.034, Table 4 ) were significant markers of survival on univariate analysis. On multivariate analysis, texture parameters entropy at coarse texture scale (HR 8.6, 95% CI: 1.8-39.8, P = 0.005) and kurtosis without filtration (HR 4.2, 95% CI: 1.4-13, P = 0.01) were the only independent predictors of RFS (Table 5 , Fig 4c,d) .
Discussion
This is the first study to assess the prognostic significance of texture features in addition to morphological MRI and histopathological parameters of rectal cancer undergoing CRT. On pre-treatment MRTA a lower MPP at fine texture was an independent predictor for all three forms of survival. A lower mean MPP at medium texture was an independent predictor of OS and DFS and kurtosis at medium texture was an independent predictor of RFS. Intra-tumour heterogeneity has been attributed to various factors such as hypoxia, necrosis, angiogenesis and genetic variations [35, 36] . Both hypoxia and necrosis reflect increased numbers of dark tumour regions which tend to give a negative mean [16] . MPP considers only pixels greater than zero and reduces the impact of dark areas on the mean histogram value. MPP has been correlated negatively with hypoxia in colorectal cancers exhibiting K-RAS mutations [37] . Lower than threshold MPP values in predicting an inferior outcome are consistent with the possibility of predominance of hypoxic areas in rectal cancer rather than angiogenesis in our study. The finding of lower kurtosis at medium texture predicting poorer DFS and RFS on post-treatment MRTA may suggest more focal radiation induced inactive fibrosis which has previously been associated with an inferior outcome in lung cancer [38] . Post-treatment MR EMVI status was an independent predictor of OS on multivariate analysis. These results are similar to those of Chand et al. [39] . In this database patients with ymrEMVI positivity had a significantly worse DFS at 3 years (42.7%) compared with ymrEMVI-negative tumours (79.8%). MRI CRM status at pre-and post-CRT was noted to be significant on multivariate analysis for DFS, while mrTRG and ymrEMVI were also significant for DFS on univariate analysis. This is similar to previous datasets from Patel et al. [19] (where mrTRG was significant on multivariate analysis for OS and DFS) and Taylor et al. [40] (where involvement of CRM on baseline MRI independently predicted OS, DFS and local recurrence on multivariate analysis). Significant univariate histopathological parameters such as ypCRM, pathological complete response and ypTRG did not predict survival independently on multivariate analysis.
Limitations of the study
There is a lack of validated published histological correlations of tumour heterogeneity for different MR texture scales in rectal cancer. This is a first exploratory and hypothesis-generating study with regard to MRTA in survival after treatment of rectal cancer. The data, however, are based on small numbers of patients from one centre. Using the same data to identify optimal cut-off values for each marker to divide the population into good and bad prognostic groups could lead to the overstatement of significant results. Acquisition parameters with MRI can introduce higher signal intense variability compared with CT or positron emission tomography which in theory could affect reproducibility of the results. The study suggests that high resolution pre-and posttreatment MRI-based assessment of CRM and EMVI status and MRTA are superior to independent imaging markers for predicting survival in locally advanced rectal cancer than the standard TNM-based MR criteria. Treatment for this group could be tailored, for example, with more intensive individualized neoadjuvant treatment before undergoing surgery and adjuvant chemotherapy.
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